Global Nanomedicine Market US$ 170 Billion by 2021

Global Nanomedicine Market US$ 170 Billion by 2021

Nanomedicine is the medical application of nanotechnology that ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines. Nanomedicines are used globally to improve the treatments and lives of patients suffering from a range of disorders including ovarian and breast cancer, kidney disease, fungal infections, elevated cholesterol, menopausal symptoms, multiple sclerosis, chronic pain, asthma and emphysema.

The global nanomedicine market is estimated to reach US$ 170 Billion in 2020, growing at a CAGR of 8.9% from 2017 to 2021, according to a market research report Nanomedicine Market 2017-2021, published by iHealthcareAnalyst, Inc.

Visit the Nanomedicine Market 2017-2021 report at

The global nanomedicine market segmentation is based on applications (neurology, cardiology, oncology, anti-inflammatory, anti-infectives, etc.).

The global nanomedicine market report provides market size (Revenue US$ Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021). The global nanomedicine market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

1. Application
1.1 Neurology
1.2 Cardiology
1.3 Oncology
1.4 Anti-inflammatory
1.5 Anti-infectives
1.6 Others

2. Geography (Region, Country)
2.1 North America (U.S., Canada)
2.2 Latin America (Brazil, Mexico, Rest of LA)
2.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4 Asia Pacific (Japan, China, India, Rest of APAC)
2.5 Rest of the World

3. Company Profiles
3.1 Abbott Laboratories
3.2 CombiMatrix Corporation
3.3 Celgene Corporation
3.4 Mallinckrodt plc
3.5 GE Healthcare
3.6 Johnson & Johnson
3.7 Merck & Company Inc.
3.8 Nanosphere, Inc.
3.9 Pfizer Inc.
3.10 Sigma-Tau Pharmaceuticals Inc.
3.11 Teva Pharmaceutical Industries Ltd.
3.12 UCB SA

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: [email protected]

2016-12-21T21:35:04+00:00 Categories: Press Releases|